India has set an ambitious target to increase its share in the $2 trillion global pharmaceutical trade from $60 billion to $450 billion by 2047. The strategy involves a major structural shift from high-volume generic drug production to high-value innovation, supported by regulatory reforms in the Central Drugs Standard Control Organisation (CDSCO). This vision aligns with the Viksit Bharat 2047 goal and is critical for India's economic and strategic positioning in the global healthcare sector.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Target Year: 2047
- ›Current Pharma Trade: $60 billion
- ›Target this Data: $450 billion pharmaceutical trade target by 2047.
- ›Target this Nodal Body: Central Drugs Standard Control Organisation (CDSCO).
- ›Target this Legal Point: Regulatory reforms for 1,500 new CDSCO positions.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.